万孚生物 (300482)

GUANGZHOU WONDFO BIOTECH CO.,LTD

ASZ

Tags

DeepSeekArtificial Intelligence (AI)Pharmaceutical ManufacturingContains Convertible BondsGene ConceptInfant and Child ConceptPet EconomyIndustrial HempHelicobacter PyloriPlanned Reduction of HoldingsHepatitis ConceptTencent ConceptMargin Trading and Securities LendingAssisted ReproductionFood SafetyChiNext 200 IndexChiNext 300 IndexChiNext InnovationChiNext Blue ChipChiNext HealthcareChiNext TechSZSE Innovation Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 46808.49
  • Circulating A-Shares(W): 43039.85
  • Earnings Per Share(RMB): 0.2800
  • Net Assets Per Share(RMB): 11.5214
  • Operating Revenue(W RMB): 169017.54
  • Total Profit(W RMB): 12661.97
  • Net Profit Attributable to Parent(W RMB): 13373.98
  • Net Profit Growth Rate(%): -69.32
  • Weighted Return on Equity(%): 2.4700
  • Operating Cash Flow Per Share(RMB): 0.1130
  • Undistributed Profit Per Share(RMB): 7.4496
  • Capital Reserve Per Share(RMB): 2.7899

2. Main Business

The main business covers:

  • Research, development, intelligent manufacturing, marketing, and service of rapid diagnostic reagents and supporting instruments.

3. Company Basic Information

  • Company Name: Guangzhou Wondfo Biotech Co., Ltd.
  • Listing Date: 2015-06-30
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 8 Lizhi Mountain Road, Science City, Luogang District, Guangzhou City, Guangdong Province, China.
  • Website: www.wondfo.com.cn
  • Company Profile: The issuer was established by the overall transformation of Guangzhou Wondfo Biotech Co., Ltd. Wondfo Co., Ltd. was established on November 13, 1992, with an initial registered capital of 300,000 RMB, funded by Li Wenmei, Luo Yichun, Wang Jihua, and Xie Yougong. In April 2012, based on the audited net assets of RMB 151,510,716.40 as of December 31, 2011, Wondfo Co., Ltd. was transformed into a joint stock company at a ratio of 1:0.43561275, resulting in a total share capital of 66 million shares with a par value of RMB 1 per share. On May 18, 2012, the company completed the industrial and commercial change registration at the Guangzhou Administration for Industry and Commerce and obtained the Business License with registration number 440101000008134.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangzhou Huiyin Tianyue Equity Investment Fund Management Co., Ltd. General Legal Person 4919.56 11.43
2 Guangzhou Biomedical and Health Industry Investment Co., Ltd. General Legal Person 901.81 2.10
3 Huabao CSI Medical ETF Fund 819.27 1.90
4 Guangdong Hengkuo Investment Management Co., Ltd. General Legal Person 588.16 1.37
5 Sequoia Jincheng (Xiamen) Equity Investment Partnership (Limited Partnership) General Legal Person 432.30 1.00
6 Southern CSI 1000 ETF Fund 264.42 0.61
7 Donghai CSI Social Development Security Industry Theme Index Fund Fund 1.73 0.00

5. Concept Sectors

  • Convertible Bonds
  • Food Safety
  • Infant & Child Concept
  • Gene Concept
  • Artificial Intelligence
  • Tencent Concept
  • Industrial Hemp
  • Helicobacter Pylori
  • Assisted Reproduction
  • Hepatitis Concept
  • Pet Economy
  • DeepSeek
  • Margin Trading & Securities Lending
  • Planned Share Reduction
  • ChiNext 300
  • SZSE Innovation
  • ChiNext Innovation
  • ChiNext Blue Chips
  • ChiNext Technology
  • ChiNext Pharmaceuticals
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information